Cargando…

Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis

We present the case of an HIV-seropositive individual with cryptococcal meningitis who was found to have a fluconazole resistant strain of Cryptococcus neoformans. The individual required multiple rounds of amphotericin and fluconazole 800–1200 mg after several episodes of clinical relapse. Cerebros...

Descripción completa

Detalles Bibliográficos
Autores principales: Mpoza, Edward, Rhein, Joshua, Abassi, Mahsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723366/
https://www.ncbi.nlm.nih.gov/pubmed/29234588
http://dx.doi.org/10.1016/j.mmcr.2017.11.004
_version_ 1783285197851066368
author Mpoza, Edward
Rhein, Joshua
Abassi, Mahsa
author_facet Mpoza, Edward
Rhein, Joshua
Abassi, Mahsa
author_sort Mpoza, Edward
collection PubMed
description We present the case of an HIV-seropositive individual with cryptococcal meningitis who was found to have a fluconazole resistant strain of Cryptococcus neoformans. The individual required multiple rounds of amphotericin and fluconazole 800–1200 mg after several episodes of clinical relapse. Cerebrospinal fluid sterilization was achieved and maintained with high doses of fluconazole. This case demonstrates the emerging dilemma of increasing rates of fluconazole resistance in Cryptococcus and the clinical difficulties in meningitis management.
format Online
Article
Text
id pubmed-5723366
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-57233662017-12-11 Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis Mpoza, Edward Rhein, Joshua Abassi, Mahsa Med Mycol Case Rep Case Report We present the case of an HIV-seropositive individual with cryptococcal meningitis who was found to have a fluconazole resistant strain of Cryptococcus neoformans. The individual required multiple rounds of amphotericin and fluconazole 800–1200 mg after several episodes of clinical relapse. Cerebrospinal fluid sterilization was achieved and maintained with high doses of fluconazole. This case demonstrates the emerging dilemma of increasing rates of fluconazole resistance in Cryptococcus and the clinical difficulties in meningitis management. Elsevier 2017-11-26 /pmc/articles/PMC5723366/ /pubmed/29234588 http://dx.doi.org/10.1016/j.mmcr.2017.11.004 Text en © 2017 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Mpoza, Edward
Rhein, Joshua
Abassi, Mahsa
Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
title Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
title_full Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
title_fullStr Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
title_full_unstemmed Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
title_short Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
title_sort emerging fluconazole resistance: implications for the management of cryptococcal meningitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723366/
https://www.ncbi.nlm.nih.gov/pubmed/29234588
http://dx.doi.org/10.1016/j.mmcr.2017.11.004
work_keys_str_mv AT mpozaedward emergingfluconazoleresistanceimplicationsforthemanagementofcryptococcalmeningitis
AT rheinjoshua emergingfluconazoleresistanceimplicationsforthemanagementofcryptococcalmeningitis
AT abassimahsa emergingfluconazoleresistanceimplicationsforthemanagementofcryptococcalmeningitis